β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.

Autor: Nakagawa C; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Kadlera Nagaraj M; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Hernandez JC; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Uthay Kumar DB; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Shukla V; University of Texas MD Anderson Cancer Center, Houston, TX, United States., Machida R; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Schüttrumpf J; Biotest AG, Dreieich, Germany., Sher L; Department of Surgery, University of Southern California, Los Angeles, CA, United States., Farci P; Hepatic Pathogenesis Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Mishra L; University of Texas MD Anderson Cancer Center, Houston, TX, United States., Tahara SM; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Ou JJ; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States., Machida K; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, United States.; Southern California Research Center for Alcoholic Liver Disease and Pancreatic Disease (ALPD) and Cirrhosis, Los Angeles, CA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Sep 08; Vol. 14, pp. 1204907. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).